The Mildred Wiesenfeld Award is presented to an individual in recognition of distinguished scholarly contributions to the clinical practice of ophthalmology. Gragoudas is this year's recipient for his pioneering achievement in the use of protein beam irradiation in the treatment of intraocular melanoma and for the development of photodynamic therapy for neovascular age-related macular degeneration.
Gragoudas is Director of Retina Service at the Massachusetts Eye and Ear Infirmary in Boston, Mass., and Professor of Ophthalmology at Harvard Medical School. He received his medical degree from National and Capodistrian University of Athens in Greece, and served his residency at Boston University. Gragoudas currently serves as Secretary of The Macula Society and on the Editorial Board of EyeNet. He is a past recipient of the Arnall Patz Medal for outstanding contributions in the study of retinal vascular diseases and the author of numerous books and peer-reviewed publications.
Established in 1928, ARVO is a membership organization of more than 11,300 eye and vision researchers from over 70 countries. The Association encourages and assists its members and others in research, training, publication, and dissemination of knowledge in vision and ophthalmology. ARVO's headquarters are located in Rockville, Md. For more information about ARVO, logon to the Association's Web site, www.arvo.org .